201 related articles for article (PubMed ID: 31289113)
21. Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast.
Pickar JH; Komm BS
Post Reprod Health; 2015 Sep; 21(3):112-21. PubMed ID: 26289836
[TBL] [Abstract][Full Text] [Related]
22. Endometrial safety: a key hurdle for selective estrogen receptor modulators in development.
Pinkerton JV; Goldstein SR
Menopause; 2010; 17(3):642-53. PubMed ID: 20107426
[TBL] [Abstract][Full Text] [Related]
23. Bazedoxifene: bazedoxifene acetate, TSE 424, TSE-424, WAY 140424.
Drugs R D; 2008; 9(3):191-6. PubMed ID: 18457472
[TBL] [Abstract][Full Text] [Related]
24. Selective estrogen receptor modulators in clinical practice: a safety overview.
Ellis AJ; Hendrick VM; Williams R; Komm BS
Expert Opin Drug Saf; 2015 Jun; 14(6):921-34. PubMed ID: 25936229
[TBL] [Abstract][Full Text] [Related]
25. Human liver aldehyde oxidase: inhibition by 239 drugs.
Obach RS; Huynh P; Allen MC; Beedham C
J Clin Pharmacol; 2004 Jan; 44(1):7-19. PubMed ID: 14681337
[TBL] [Abstract][Full Text] [Related]
26. Differential effects of selective estrogen receptor modulators on the vagina and its supportive tissues.
Liang R; Knight K; Nolfi A; Abramowitch S; Moalli PA
Menopause; 2016 Feb; 23(2):129-37. PubMed ID: 26382313
[TBL] [Abstract][Full Text] [Related]
27. Clinical issues regarding cardiovascular disease and selective estrogen receptor modulators in postmenopausal women.
de Villiers TJ
Climacteric; 2009; 12 Suppl 1():108-11. PubMed ID: 19811253
[TBL] [Abstract][Full Text] [Related]
28. Structural insights into xenobiotic and inhibitor binding to human aldehyde oxidase.
Coelho C; Foti A; Hartmann T; Santos-Silva T; Leimkühler S; Romão MJ
Nat Chem Biol; 2015 Oct; 11(10):779-83. PubMed ID: 26322824
[TBL] [Abstract][Full Text] [Related]
29. The 2.0 A crystal structure of the ERalpha ligand-binding domain complexed with lasofoxifene.
Vajdos FF; Hoth LR; Geoghegan KF; Simons SP; LeMotte PK; Danley DE; Ammirati MJ; Pandit J
Protein Sci; 2007 May; 16(5):897-905. PubMed ID: 17456742
[TBL] [Abstract][Full Text] [Related]
30. Emerging selective estrogen receptor modulators: special focus on effects on coronary heart disease in postmenopausal women.
Vogelvang TE; van der Mooren MJ; Mijatovic V; Kenemans P
Drugs; 2006; 66(2):191-221. PubMed ID: 16451093
[TBL] [Abstract][Full Text] [Related]
31. Lasofoxifene (CP-336,156), a selective estrogen receptor modulator, prevents bone loss induced by aging and orchidectomy in the adult rat.
Ke HZ; Qi H; Crawford DT; Chidsey-Frink KL; Simmons HA; Thompson DD
Endocrinology; 2000 Apr; 141(4):1338-44. PubMed ID: 10746637
[TBL] [Abstract][Full Text] [Related]
32. Selective estrogen modulators in menopause.
Gambacciani M
Minerva Ginecol; 2013 Dec; 65(6):621-30. PubMed ID: 24346250
[TBL] [Abstract][Full Text] [Related]
33. Differential effects of estrogen and raloxifene on messenger RNA and matrix metalloproteinase 2 activity in the rat uterus.
Helvering LM; Adrian MD; Geiser AG; Estrem ST; Wei T; Huang S; Chen P; Dow ER; Calley JN; Dodge JA; Grese TA; Jones SA; Halladay DL; Miles RR; Onyia JE; Ma YL; Sato M; Bryant HU
Biol Reprod; 2005 Apr; 72(4):830-41. PubMed ID: 15576828
[TBL] [Abstract][Full Text] [Related]
34. Selective estrogen receptor modulators protect hippocampal neurons from kainic acid excitotoxicity: differences with the effect of estradiol.
Ciriza I; Carrero P; Azcoitia I; Lundeen SG; Garcia-Segura LM
J Neurobiol; 2004 Nov; 61(2):209-21. PubMed ID: 15389604
[TBL] [Abstract][Full Text] [Related]
35. Selective Estrogen Receptor Modulators.
An KC
Asian Spine J; 2016 Aug; 10(4):787-91. PubMed ID: 27559463
[TBL] [Abstract][Full Text] [Related]
36. The future of the new selective estrogen receptor modulators.
Palacios S
Menopause Int; 2007 Mar; 13(1):27-34. PubMed ID: 17448265
[TBL] [Abstract][Full Text] [Related]
37. Interspecies differences in the metabolism of methotrexate: An insight into the active site differences between human and rabbit aldehyde oxidase.
Choughule KV; Joswig-Jones CA; Jones JP
Biochem Pharmacol; 2015 Aug; 96(3):288-95. PubMed ID: 26032640
[TBL] [Abstract][Full Text] [Related]
38. Selective estrogen receptor modulators: an update on recent clinical findings.
Shelly W; Draper MW; Krishnan V; Wong M; Jaffe RB
Obstet Gynecol Surv; 2008 Mar; 63(3):163-81. PubMed ID: 18279543
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory effects of drugs on the metabolic activity of mouse and human aldehyde oxidases and influence on drug-drug interactions.
Takaoka N; Sanoh S; Okuda K; Kotake Y; Sugahara G; Yanagi A; Ishida Y; Tateno C; Tayama Y; Sugihara K; Kitamura S; Kurosaki M; Terao M; Garattini E; Ohta S
Biochem Pharmacol; 2018 Aug; 154():28-38. PubMed ID: 29678521
[TBL] [Abstract][Full Text] [Related]
40. Modulators of androgen and estrogen receptor activity.
Clarke BL; Khosla S
Crit Rev Eukaryot Gene Expr; 2010; 20(4):275-94. PubMed ID: 21395502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
